Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
26 Results Found
Fact Sheet: The 340B Drug Pricing Program
Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients by providing 340B drug pricing discounts and expand health services to the patients and communities they serve.
Resources to Address 340B Underpayments by Medicare Advantage Organizations
To assist members in their efforts to obtain reimbursement under their contracts with their MAO plans, we have identified and spoken with four outside law firms that have considerable experience with 340B questions and litigating against insurers on issues like these.
HHS Issues Final Remedy for Its Unlawful 340B Payment Cuts from 2018 to 2022
Following last year’s unanimous Supreme Court decision in favor of the AHA and others, the Department of Health and Human Services Nov. 2 issued a final rule outlining the agency’s remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program.
Resource on Withdrawal of Health Care Antitrust Policy Statements
The Department of Justice in February abruptly withdrew three policy statements on health care antitrust enforcement.
Judge Rules that HHS Must Immediately Halt Unlawful Reimbursement Cuts to Certain 340B Hospitals for Rest of 2022
The United States District Court for the District of Columbia today ruled in favor of the AHA, holding that the Department of Health and Human Services must immediately halt the departments’ unlawful cuts to outpatient reimbursement rates for the remainder of 2022 for certain hospitals that participate in the 340B Drug Pricing Program.
Supreme Court Rules Unanimously in Favor of AHA, Others in 340B Case
The Supreme Court of the United States today
AHA to Department of Justice Re: False Claims Act investigations
The AHA urges the Department of Justice to establish a task force to conduct False Claims Act investigations into commercial health insurance companies that are found to routinely deny patients access to services and deny payments to health care providers.
Supreme Court Allows CMS Vaccine Mandate to Go into Effect, Blocks OSHA Vaccine Requirements
The U.S. Supreme Court today allowed the Centers for Medicare & Medicaid Services (CMS) vaccine mandate to go into effect nationwide, while blocking the Occupational Safety and Health Administration’s (OSHA) vaccine requirements from taking effect.
Hospital and Physician Groups File Lawsuit Over No Surprises Act Final Rules That Jeopardize Patient Access to Care
The American Hospital Association (AHA) and American Medical Association (AMA) sued the federal government today over the misguided implementation of the federal surprise billing law. The associations are joined in the suit by hospital and physician plaintiffs, including Renown Health, UMass Memorial Health and two physicians based in North Carolina.
340B Advocacy Alliance Bulletin: Federal District Judge Issues Ruling In Eli Lilly 340B Contract Pharmacy Case
A federal district court judge in Indiana Friday agreed with the government’s contention that the 340B statute would permit the Department of Health and Human Services to require that the drug company Eli Lilly offer 340B discounts for drugs distributed by hospitals through community pharmacies, finding that this was the best reading of the what the 340B statute requires